Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope.

Authors: Al-Omari, Mothana K., Elaarag, Mai, Al-Zoubi, Raed M., Al-Qudimat, Ahmad R., Zarour, Ayman A., Al-Hurani, Enas A., Fares, Zainab E., Alkharraz, Leena M., Shkoor, Mohanad, Bani-Yaseen, Abdulilah D., Aboumarzouk, Omar M., Yassin, Aksam, Al-Ansari, Abdulla A.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry; Dec2023, Vol. 38 Issue 1, p1-16, 16p

Subject Terms: PRODRUGS, ESTERS, ESTER derivatives, CANCER treatment, MULTIPLE myeloma, LUNG cancer, BORONIC acids

Company/Entity: CANADA. Health Canada, UNITED States. Food & Drug Administration